- Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD
-
Kang W, Kim SU
- KMID: 1705202
- Clin Mol Hepatol.
- 2013 Sep;19(3):255-257.
- doi: 10.3350/cmh.2013.19.3.255
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1705201
- Clin Mol Hepatol.
- 2013 Sep;19(3):216-254.
- doi: 10.3350/cmh.2013.19.3.216
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Epithelioid hemangioendothelioma of the liver
-
Choi KH, Moon WS
- KMID: 1705211
- Clin Mol Hepatol.
- 2013 Sep;19(3):315-319.
- doi: 10.3350/cmh.2013.19.3.315
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
-
Koo SH
- KMID: 1705200
- Clin Mol Hepatol.
- 2013 Sep;19(3):210-215.
- doi: 10.3350/cmh.2013.19.3.210
Liver plays a central role in the biogenesis of major metabolites including glucose, fatty acids, and cholesterol. Increased incidence of obesity in the modern society promotes insulin resistance in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary hepatic lymphoma mimicking acute hepatitis
-
Lee JA, Jeong WK, Min JH, Kim J
- KMID: 1705212
- Clin Mol Hepatol.
- 2013 Sep;19(3):320-323.
- doi: 10.3350/cmh.2013.19.3.320
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
-
Yim HJ, Hwang SG
- KMID: 1705199
- Clin Mol Hepatol.
- 2013 Sep;19(3):195-209.
- doi: 10.3350/cmh.2013.19.3.195
Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Genotype-4 hepatitis E in a human after ingesting roe deer meat in South Korea
-
Choi JY, Lee JM, Jo YW, Min HJ, Kim HJ, Jung WT, Lee OJ, Yun H, Yoon YS
- KMID: 1705210
- Clin Mol Hepatol.
- 2013 Sep;19(3):309-314.
- doi: 10.3350/cmh.2013.19.3.309
The recent increase in the number of cases of indigenous hepatitis E virus (HEV) infection highlights the importance of identifying the transmission routes for the prevention of such infections. Presented... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
-
Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW
- KMID: 1705208
- Clin Mol Hepatol.
- 2013 Sep;19(3):300-304.
- doi: 10.3350/cmh.2013.19.3.300
BACKGROUND/AIMS: Relapse has been reported after stopping nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- Co-development of autoimmune hepatitis and Sjogren's syndrome triggered by the administration of herbal medicines
-
Oh HJ, Mok YM, Baek MS, Lee JK, Seo BS, Kim TH, Choi KH, Hwang IK, Ra JE, Oh YR, Kim YS, Cho EY, Kim HC, Sohn YW
- KMID: 1705209
- Clin Mol Hepatol.
- 2013 Sep;19(3):305-308.
- doi: 10.3350/cmh.2013.19.3.305
Autoimmune hepatitis (AIH) has been reported in association with Sjogren's syndrome (SS). Drug-induced AIH has been rarely reported. A rare case of the co-development of AIH and SS in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated red cell distribution width is associated with advanced fibrosis in NAFLD
-
Kim HM, Kim BS, Cho YK, Kim BI, Sohn CI, Jeon WK, Kim HJ, Park DI, Park JH, Joo KJ, Kim CJ, Kim YS, Heo WJ, Choi WS
- KMID: 1705203
- Clin Mol Hepatol.
- 2013 Sep;19(3):258-265.
- doi: 10.3350/cmh.2013.19.3.258
BACKGROUND/AIMS: The red-blood-cell distribution width (RDW) is a newly recognized risk marker in patients with cardiovascular disease, but its role in nonalcoholic fatty liver disease (NAFLD) has not been well... -
- CITED
-
- Close
- SHARE
-
- Close
- Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea
-
Jeong EH, Jun DW, Cho YK, Choe YG, Ryu S, Lee SM, Jang EC
- KMID: 1705204
- Clin Mol Hepatol.
- 2013 Sep;19(3):266-272.
- doi: 10.3350/cmh.2013.19.3.266
BACKGROUND/AIMS: The prevalence of nonalcoholic fatty liver disease (NAFLD) in Korea has increased recently. The aim of the present study was to determine the regional differences in the prevalence and... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
-
Kim JH, Ko SY, Choe WH, Kwon SY, Lee CH
- KMID: 1705205
- Clin Mol Hepatol.
- 2013 Sep;19(3):273-279.
- doi: 10.3350/cmh.2013.19.3.273
BACKGROUND/AIMS: Lamivudine (LAM) plus adefovir (ADV) combination therapy has been accepted as one of the best treatments for LAM-resistant chronic hepatitis B (CHB). The aim of this study was to... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
-
Oh MJ, Lee HJ, Lee SH
- KMID: 1705207
- Clin Mol Hepatol.
- 2013 Sep;19(3):288-299.
- doi: 10.3350/cmh.2013.19.3.288
BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and cisplatin for intractable advanced hepatocellular carcinoma (HCC) may have survival benefits. We aimed to determine the efficacy and safety of HAIC... -
- CITED
-
- Close
- SHARE
-
- Close
- The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding
-
Choi MH, Kim YS, Kim SG, Lee YN, Seo YR, Kim MJ, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS
- KMID: 1705206
- Clin Mol Hepatol.
- 2013 Sep;19(3):280-287.
- doi: 10.3350/cmh.2013.19.3.280
BACKGROUND/AIMS: The most appropriate treatment for acute gastric variceal bleeding (GVB) is currently endoscopic gastric variceal obturation (GVO) using Histoacryl(R). However, the secondary prophylactic efficacy of beta-blocker (BB) after GVO... -
- CITED
-
- Close
- SHARE
-
- Close
